Evidence map›Paper›PMID 31837915›Full record

ArticleNeuron2020

A Discrete Presynaptic Vesicle Cycle for Neuromodulator Receptors.

Damien Jullié, Miriam Stoeber, Jean-Baptiste Sibarita, Hanna L Zieger, Thomas M Bartol, Seksiri Arttamangkul, Terrence J Sejnowski, Eric Hosy, Mark von Zastrow

Open access · bronzeAbstract read
In one paragraph

Article in Neuron, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
3.1field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 54 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Opioid receptors reveal a discrete cellular mechanism of endosomal G protein activation.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 3 countries.

Damien JulliéDepartment of Cellular and Molecular Pharmacology, University of California, San Francisco School of Medicine, San Francisco, CA 94158, USA; Department of Psychiatry, University of California, San Francisco School of Medicine, San Francisco, CA 94158, USA.
Miriam StoeberDepartment of Cellular and Molecular Pharmacology, University of California, San Francisco School of Medicine, San Francisco, CA 94158, USA; Department of Psychiatry, University of California, San Francisco School of Medicine, San Francisco, CA 94158, USA; Department of Cell Physiology and Metabolism, University of Geneva, 1211 Geneva, Switzerland.
Jean-Baptiste SibaritaInterdisciplinary Institute for Neuroscience, UMR 5297, Centre National de la Recherche Scientifique, 33077 Bordeaux, France; Interdisciplinary Institute for Neuroscience, University of Bordeaux, 33077 Bordeaux, France.
Hanna L ZiegerInterdisciplinary Institute for Neuroscience, UMR 5297, Centre National de la Recherche Scientifique, 33077 Bordeaux, France; Interdisciplinary Institute for Neuroscience, University of Bordeaux, 33077 Bordeaux, France.
Thomas M BartolHoward Hughes Medical Institute, Salk Institute for Biological Studies, La Jolla, CA 92037, USA.
Seksiri ArttamangkulThe Vollum Institute, Oregon Health and Science University, Portland, OR 97239, USA.
Terrence J SejnowskiHoward Hughes Medical Institute, Salk Institute for Biological Studies, La Jolla, CA 92037, USA.
Eric HosyInterdisciplinary Institute for Neuroscience, UMR 5297, Centre National de la Recherche Scientifique, 33077 Bordeaux, France; Interdisciplinary Institute for Neuroscience, University of Bordeaux, 33077 Bordeaux, France.
Mark von ZastrowDepartment of Cellular and Molecular Pharmacology, University of California, San Francisco School of Medicine, San Francisco, CA 94158, USA; Department of Psychiatry, University of California, San Francisco School of Medicine, San Francisco, CA 94158, USA. Electronic address: mark@vzlab.org.
Université de Bordeaux · FRSalk Institute for Biological Studies · USUniversity of California, San Francisco · USOregon Health & Science University · USUniversity of Geneva · CH

Funding

PROTEINS REGULATING ENDOCYTOSIS OF OPIOID RECEPTORSR01DA012864 · NIDA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Mark E Von Zastrow · 2000 to 2026
$7.9M
Membrane Trafficking of Opioid and Adrenergic ReceptorsR01DA010711 · NIDA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI VONZASTROW, MARK E · 2014 to 2023
$4.6M
MEMBRANE TRAFFICKING OF OPIOID RECEPTORSR37DA010711 · NIDA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI VONZASTROW, MARK E · 2004 to 2013
$3.1M
CRCNS: Regulating AMPAR trapping and desensitization in the postsynaptic density R01MH115556 · NIMH · SALK INSTITUTE FOR BIOLOGICAL STUDIES · PI SEJNOWSKI, TERRENCE J · 2017 to 2020
$1.2M
Opioid Sensitive GABA inputs to the Ventral MidbrainR01DA034388 · NIDA · OREGON HEALTH & SCIENCE UNIVERSITY · PI WILLIAMS, JOHN T · 2012 to 2016
$967k
Covalent labeling endogenous G-protein coupled receptors in living cellsR21DA048136 · NIDA · OREGON HEALTH & SCIENCE UNIVERSITY · PI WILLIAMS, JOHN T · 2019 to 2020
$424k
MEMBRANE TRAFFICKING OF OPIOID RECEPTORSR29DA010711 · NIDA · UNIVERSITY OF CALIFORNIA SAN FRANCISCO · PI VON ZASTROW, MARK E. · 1997 to 2003
$413k
NIDA NIH HHS R01 DA010711NIDA NIH HHS R01 DA012864NIDA NIH HHS R01 DA034388NIDA NIH HHS R21 DA048136NIDA NIH HHS R29 DA010711NIDA NIH HHS R37 DA010711NIMH NIH HHS R01 MH115556
6 · The paper itself

Abstract

A major function of GPCRs is to inhibit presynaptic neurotransmitter release, requiring ligand-activated receptors to couple locally to effectors at terminals. The current understanding of how this is achieved is through receptor immobilization on the terminal surface. Here, we show that opioid peptide receptors, GPCRs that mediate highly sensitive presynaptic inhibition, are instead dynamic in axons. Opioid receptors diffuse rapidly throughout the axon surface and internalize after ligand-induced activation specifically at presynaptic terminals. We delineate a parallel regulated endocytic cycle for GPCRs operating at the presynapse, separately from the synaptic vesicle cycle, which clears activated receptors from the surface of terminals and locally reinserts them to maintain the diffusible surface pool. We propose an alternate strategy for achieving local control of presynaptic effectors that, opposite to using receptor immobilization and enforced proximity, is based on lateral mobility of receptors and leverages the inherent allostery of GPCR-effector coupling.

Indexed as

Analgesics, OpioidAnimalsCells, CulturedEndocytosisEnkephalin, Ala(2)-MePhe(4)-Gly(5)-Presynaptic TerminalsProtein TransportRatsRats, Sprague-DawleyReceptors, G-Protein-CoupledReceptors, NeurotransmitterSynaptic VesiclesAnalgesics, OpioidEnkephalin, Ala(2)-MePhe(4)-Gly(5)-Receptors, G-Protein-CoupledReceptors, Neurotransmitter

Identifiers

PMID31837915
PMCPMC7035187
OpenAlexW2996756368

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.